.png)
Principle Investigator
NCATS, NIH
Dr. Inglese directs the Assay Development and Screening Technology laboratory focused on rare and neglected disease within the National Center for Advancing Translational Sciences and is an Adjunct Investigator of the National Human Genome Research Institute. Prior to this he co-founded the NIH Chemical Genomics Center. Dr. Inglese received his Ph.D. in Organic Chemistry from the Pennsylvania State University and completed post-doctoral training with Prof. Robert J. Lefkowitz at Duke University Medical Center. Before coming to the NIH, Dr. Inglese led research teams at the Princeton-based biotech Pharmacopeia and Merck Research Laboratories. Dr. Inglese has contributed to over 200 publications and patents; he has focused his efforts on the early drug discovery process through the development of novel assay formats and high throughput screening paradigms. Dr. Inglese has served on the scientific advisory boards of several NIH-funded chemistry and screening centers and international chemical biology consortia.